Diapositive 1 - Latvijas Zinātņu Akadēmija

Download Report

Transcript Diapositive 1 - Latvijas Zinātņu Akadēmija

EUROpean network of
transnational collaborative RTD projects
in the field of NANOMEDicine
1
www.euronanomed.net
What are the societal needs?
- the challenge for Europe
Improve public health and welfare
– Ageing population
– Efficiency of current medical
solutions
– Emergence of new disease and old
diseases are back
– Personalized medicine future
directions
www.euronanomed.net
2
The global challenge
• Therapeutic solutions for only
1/3 known diseases (WHO)
• Infections: HIV, TB, malaria,
risk of pandemia
• Need to increase capability
and innovation of medical
industry
– Rapid and accurate diagnosis for
early detection, even prevention
– Novel, more efficient therapies with
less side effects
www.euronanomed.net
3
Nano from research
to patient and industry
Nanomedicine: the application of nanotechnology
to achieve breakthroughs in healthcare
Foto: kaibara87/www.flickr.com
www.euronanomed.net
4
Emerging nanomedicine
www.euronanomed.net
5
Principle of the
ERA-net scheme
ES
G
UK
F
CP
DE
CP
CP
With ERA-Net
CP
CP
Without ERA-Net
Prog
Prog
F
G
Prog Prog
UK
ES
Prog
DE
…
(CP: Call for projects)
Common transnational dedicated CP
€ : EC supports the coordination costs. Each national programme
supports their national partners within the selected projects
www.euronanomed.net
6
EuroNanoMed covers
3/4 of European
nanomedicine actors
• 24 partners from 18
countries/regions
• Coordination of funding
programmes in nanomedicine
• Started January 2009
• EU funding for coordination
(ERA-net in FP7)
2 common joint calls for
proposals 2009, 2010
www.euronanomed.net
7
EuroNanoMed: an asset to
bridge the gap
Aims of the Calls
Develop innovative diagnostic and therapeutic solutions
for the patient
Solving unmet medical needs
Enhancing the competitiveness of the European health
industry
Maturation of the Nanomedicine field in Europe
Cross-border collaboration between the best researchers /
teams in Nanomedicine, bringing together teams from
 academic / public research
 clinical / public health
 industry
www.euronanomed.net
8
Why now?
What’s the urgency?
• Health industry: a key for future
growth
• European countries invest
substantially in nano industry
and basic nano research
• Nano technologies: a promising
field for innovation and patient
application
Despite these efforts, Europe is lagging behind the US
in an increasing competition :
Europe needs to act now!
www.euronanomed.net
9
Expected outcome
• To move innovation from knowledge to
industrial technology and health care
applications
• Opening the national programmes to support
transnational RTD partnerships
Long term vision:
formula for an Europeanwide integrated programme
with a coordinated funding
www.euronanomed.net
10
Contacts
• Coordinator and Executive Board Chair
Dr. Virginie Sivan
Commissariat à l’Energie Atomique (CEA)
[email protected]
 (+33) 1 69 08 87 99
• Network Steering Committee chair
Dr. Olaf Rotthaus
VDI Technologiezentrum GmbH (VDI)
[email protected]
 (+49) 211 6214-233
www.euronanomed.net
11
EuroNanoMed:
1st Joint Transnational Call
Call open from May 25th to September 1st 2009
Evaluation by Peer Review Panel in September 2009
Call Steering Committee decision in October 2009
8 Projects selected for funding
(40 Partners, 14 Countries /Regions)
Selected projects have recently started to work or are
about to start.
Total costs of funded projects: 16.9 M €
Total requested budget 9.4 M €
www.euronanomed.net
12
EuroNanoMed:
1st Joint Transnational Call
Applicants per Country
Funded Partners
20
France
8
Spain
8
Germany
7
14
Sweden
4
12
Switzerland
3
10
The Netherlands
2
8
Denmark (NPC)
1
6
Israel
1
Italy (NPC)
1
Veneto Region
1
Lithuania
1
Poland
1
Portugal
1
Basque Region
1
18
Funded Projects
Non funded Projects
16
4
2
0
um
gi
el
d
(B
an
n
el
io
Ic a
i
eg )
tv R
La on PC
lo (N
al
W ark
m )
)
in
en
D PC
pa
(N
(S
K
U y gi on
e
rk Re
Tu ue
sq a
Ba ani
u
th
Li
nd
l a C)
n)
Po P
N
io
(
ly
eg
Ita ani a o R
et
om n
R (Ve
ly l
Ita ga
s
rt u
nd
Po l
rla
e
ra he
Is et
N
e and
Th erl
itz
Sw
n
ai
Sp en
ed y
Sw an
m
er
G ce
n
a
Fr
)
www.euronanomed.net
13
EuroNanoMed:
1st Joint Transnational Call
Funded projects per thematic subfield
1; 12,5%
2
1; 12,5%
Targeted delivery systems
Regenerative medicine
Diagnostics & Targeted
delivery systems
4; 50%
Targeted delivery systems &
Regenerative medicine
www.euronanomed.net
14
EuroNanoMed: open Call
2nd Joint Transnational
Call for Proposals
17 Partners from
16 Countries / Regions
Deadline: June 11
www.euronanomed.net
15
Participating Funding Organisations
Industry, Innovation, Trade and Tourism Department, Basque
Government
The French National Research Agency (ANR)
VDI Technologiezentrum GmbH
National Office for Research and Technology (NKTH)
The Icelandic Centre for Research (RANNIS)
The Chief Scientist Office, The Ministry of Health (CSO-MOH)
The Latvian Academy of Sciences (LAS)
Science Council of Lithuania (LSC)
National Centre for Research and Development (NCBiR)
Fundação para a Ciência e a Tecnologia (FCT)
National Center for Programme Management (CNMP)
Instituto de Salud Carlos III (ISCIII)
The Swedish Research Council (SRC) (Vetenskapsrådet)
The Swedish Governmental Agency for Innovation Systems
(VINNOVA )
Swiss National Science Foundation (SNSF)
The Scientific and Technological Research Council of Turkey
(TUBITAK)
Ministry of the Walloon Region: Operational General Directorate
for Economy, Employment,and Research (DGOEER)
www.euronanomed.net
BASQUE REGION (SPAIN)
FRANCE
GERMANY
HUNGARY
ICELAND
ISRAEL
LATVIA
LITHUANIA
POLAND
PORTUGAL
ROMANIA
SPAIN
SWEDEN
SWEDEN
SWITZERLAND
TURKEY
WALLOON REGION
(BELGIUM)
16
Topics / Funding
Topics
Diagnostics (incl. Imaging)
Targeted drug delivery
Regenerative medicine
Funding
Indicative total funding 12 M €
Duration: Up to 3 years
Every project partner will receive
the funding from his national
agency
www.euronanomed.net
17
Eligibility criteria
Consortium composition
3 – 7 partners per consortium
Partners from at least 3 different countries
(with a majority of partners from funding member states/regions participating
in the call)
Partners from at least two of the three categories
 academic / public research
 clinical / public health
 industry
Eligibility of partners also depends on national regulation in
his/her country!
Read carefully the “Country specific information for applicants”
Contact your national agency (contact person)
www.euronanomed.net
18
Time lines
Call open since:
March 8th 2010
Deadline for proposals: June 11th 2010,
17:00 h (Brussels Time)
Funding Decision:
October 2010
Start of Projects:
January 2011
www.euronanomed.net
19
How to apply?
1. EuroNanoMed Website
www.euronanomed.net
www.euronanomed.net
20
How to apply?
2. Download Call Text , Guidelines for
applicants and Country specific Information
www.euronanomed.net
21
How to apply?
3. Contact your national contact point
(list in the Country specific Information)
4. Download and fill in the Proposal Template
www.euronanomed.net
22
How to apply?
5. Online Submission using the
EuroNanoMed Submission Tool
www.nanomedsubmission.net
www.euronanomed.net
23
How to apply?
Register by clicking on the link ”to register” on the homepage
http://www.euronanomed.net/*; you will receive an email
confirming your registration
Accede to the EuroNanoMed Electronic Submission System*
(Use the username and password you chose for the registration)
fill in all the details and upload your proposal document (pdf
format only), which you have previously filled in on your computer
(see The Proposal Template)*.
Submit your proposal : Click on “submit proposal” to confirm
your submission; you will receive an email confirming its receipt.
Modify your data at any time until the submission deadline.
It is strongly recommended to transfer the final version
in proper time before this date
www.euronanomed.net
24
Expression of Interest Tool
Present your project ideas
Find partners
www.nanomedsubmission.net
www.euronanomed.net
25
For more information
EuroNanoMed Call Office
Veneto Nanotech s.c.p.a.
Via San Crispino, 106
35129 Padova – Italy
 : +39 049 7705520
e-mail: [email protected]
National / Regional Contact Points
www.euronanomed.net
www.euronanomed.net
26
Together we are building
Nanomedicine for the future!
27
www.euronanomed.net